The Drug Controller General of India has approved the Phase 2 and 3 clinical trials of India's first Covid-19 mRNA vaccine.

Pune-based pharma major Gennova Biopharmaceuticals Ltd is developing the nation's first mRNA-based Covid-19 vaccine.

It is among a few pharmaceutical firms worldwide, including Moderna Inc and Pfizer Inc, to use mRNA technology in its coronavirus shot.
https://fit.thequint.com/health-news/dcgi-gives-nod-for-phase-23-tr...